Skip to content
Annika Bansal – Lifestyle
Author:
Cipla USA Inc.
Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA
April 23, 2026
Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis
April 2, 2026
Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy
March 5, 2026